Buy Cogint Stock | COGT Stock Price & Latest News | Public
COGT

Cogint

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About COGT

    Cogent Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. The firm’s technologies include Antibody-Co...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.16
    -0.24
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.04

    Actual EPS
    Q4 2020

    Stats

    Market Cap$117,53M
    Volume2,62k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$3.72
    1 Year Low$0.30
    Open$2.70
    High$2.83
    Low$2.69

    Buy any stock with any amount of money.

    Download the App
    Download the app